TrimRx highlights success stories to inspire new clients to keep going
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, et al., for the STEP 1 Study Group
Primary antibodies used were mouse monoclonal anti-Gpx3 (Abcam, Cambridge, UK, 1:50 or 1:100) and rabbit polyclonal anti-Collagen I antibody (Rockland, Gilbertsville, PA, USA, 1:200)
As a lyophilized powder, AHK-Cu is generally reported in the literature as stable under proper storage, with the copper-peptide complex conferring a degree of oxidative resistance relative to uncomplexed peptide chains
Tukaj, S